Here’s why penny stocks like GGE, NEXI, ALT, HCDI are pumping

December 01, 2023 07:59 AM PST | By Invezz
Follow us on Google News:

Penny stocks like Green Giant (GGE), Neximmune (NEXI), Altimmune (ALT), and Harbor Custom Development (HCDI) were among the best-performing companies in Wall Street on Friday. All of them jumped by more than 40% even as the Nasdaq 100 and S&P 500 indices pulled back. 

These companies have not made any headlines on Friday, making their surge quite difficult to explain. As I wrote in my article on ShiftPixy (PIXY), these penny stocks are rising because they are being pumped by social media users. A closer look shows that they are all trending in key social media platforms like StockTwits and Reddit. 

Penny stocks and meme companies like GameStop, AMC, and Genius Group have been quite popular in the past few weeks. Their popularity increased after the US published encouraging consumer inflation data in November. The data revealed that the country’s inflation dropped to 3.2% in October.

Another key denominator of these companies is how small they are. Green Giant, a Chinese real estate developer, has a market cap of over $10.2 million. It is a loss-making company that lost over $108 million in the last financial year.

Similarly, Harbor Custom Development, is a real estate company valued at over $3.98 million. It is also a cash incinerator that made a total loss of over $19.6 million in the last financial year.

Neximmune (NEXI), on the other hand, is a clinical biotech company that is building products to treat leukemia and myeloma. It has a market cap of over $2.6 million and its losses jumped from $50.9 million in 2021 to $62.5 million. Nexi stock price was halted after its stock surged by over 300%.

The only penny stock that had a catalyst was Altimmune, which jumped by over 51%. The company’s shares surged after a report by JMP hailed the company for its weight loss drug. In a note, the analysts said:

“Pemvidutide has a competitive profile based on the top-line MOMENTUM data with greater weight loss than semaglutide, better lipid changes and tolerability than tirzepatide, and better cardiac safety than retatrutide.”

The post Here’s why penny stocks like GGE, NEXI, ALT, HCDI are pumping appeared first on Invezz


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.

Top Listed Companies